CABG Medical Announces Q3 2005 Results and Expands Its Clinical Trial
3rd Nov 2005, 16:48 GMT
CABG Medical, the developer of an innovative drug-eluting graft for coronary artery bypass surgery, reported results for Q3 of FYE 2005.
CABG Medical Announces Q3 2005 Results and Expands Its Clinical Trial related news:
- NMT Medical Announces Q3 2005 Financial Results — Physician News News from StratCenter.com
- Curon Medical Announces Q3 and 9-Month 2005 Financial Results — Operations-Related News from StratCenter.com
- Extendicare Announces Q3 Results — Medicare/ Medicaid News from StratCenter.com
- Bio-Rad Reports Q3 Financial Results — Distribution/ Logistics News from StratCenter.com
- Advanced Medical Optics Announces Q3 2005 Results — Operations-Related News from StratCenter.com
- Neurogen Announces 11/8/2005 Webcast of Q3 2005 Financial Results — Operations-Related News from StratCenter.com
- DOBI Medical Int'l Retains Beardsworth Consulting Group for ComfortScan PMA Clinical Trial — Financial News News from StratCenter.com
- Clinicans warned about randomized clinical trials — News-Medical News Feed
- NMT Medical Announces New Organizational Structure in its European Operations — Physician News News from StratCenter.com
- Osteotech Announces Q3 Earnings Release and Conference Call Schedule — Financial News News from StratCenter.com
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease